Literature DB >> 8347499

Measurement of growth rate of lung metastases in 21 patients with bone or soft-tissue sarcoma.

C Blomqvist1, T Wiklund, M Tarkkanen, I Elomaa, M Virolainen.   

Abstract

The volume doubling time (T2) of 52 lung metastases in 21 patients was calculated from measurements done on plain chest radiographs. Follow-up times ranged from 14 to 819 days. The measurements were fairly well reproducible in the majority of patients, although considerable discrepancies in T2 estimates made by two independent observers were found in a few patients. The median doubling time was 34.9 days (estimated 95% range 3.9 to 352 days). The variation of T2:s between patients was significantly (P = 0.0001) larger than that between T2: of multiple metastases in the same patients. The growth of the metastases seemed to be well described by a simple exponential function in all patients with more than two measurements, without evidence of Gompertzian growth. There seemed to be a linear correlation between the logarithm of T2 and log-survival time from diagnosis of metastatic disease, even if only one third of the variation of survival times between patients could be explained by differences in T2. T2 was not a significant factor for survival in Cox-analysis (P = 0.10).

Entities:  

Mesh:

Year:  1993        PMID: 8347499      PMCID: PMC1968540          DOI: 10.1038/bjc.1993.351

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  RATES OF GROWTH OF PULMONARY METASTASES AND HOST SURVIVAL.

Authors:  J S SPRATT; T L SPRATT
Journal:  Ann Surg       Date:  1964-02       Impact factor: 12.969

2.  Growth rate of pulmonary metastases from soft tissue sarcoma.

Authors:  B Rööser; H Pettersson; T Alvegård
Journal:  Acta Oncol       Date:  1987       Impact factor: 4.089

3.  Statistical methods for assessing observer variability in clinical measures.

Authors:  P Brennan; A Silman
Journal:  BMJ       Date:  1992-06-06

4.  Relationship between tumor doubling time and anatomoclinical features in 50 measurable pulmonary cancers.

Authors:  P Chahinian
Journal:  Chest       Date:  1972-04       Impact factor: 9.410

5.  Relation between the pathological nature and the growth rate of human tumors.

Authors:  A Charbit; E P Malaise; M Tubiana
Journal:  Eur J Cancer       Date:  1971-08       Impact factor: 9.162

6.  Prognostic significance of tumor doubling time in evaluating operability in pulmonary metastatic disease.

Authors:  W L Joseph; D L Morton; P C Adkins
Journal:  J Thorac Cardiovasc Surg       Date:  1971-01       Impact factor: 5.209

7.  Prognostic value of doubling time in lung cancer.

Authors:  K Mattson; L R Holsti
Journal:  Strahlentherapie       Date:  1980-09

8.  DYNAMICS OF TUMOUR GROWTH: COMPARISON OF GROWTH RATES AND EXTRAPOLATION OF GROWTH CURVE TO ONE CELL.

Authors:  A K LAIRD
Journal:  Br J Cancer       Date:  1965-06       Impact factor: 7.640

9.  The study by graphical analysis of the growth of human tumours and metastases of the lung.

Authors:  M W Brenner; L R Holsti; Y Perttala
Journal:  Br J Cancer       Date:  1967-03       Impact factor: 7.640

10.  DYNAMICS OF TUMOR GROWTH.

Authors:  A K LAIRD
Journal:  Br J Cancer       Date:  1964-09       Impact factor: 7.640

View more
  6 in total

1.  Clinical impact of the tumor volume doubling time on sarcoma patients with lung metastases.

Authors:  Tomoki Nakamura; Akihiko Matsumine; Takao Matsubara; Kunihiro Asanuma; Astumasa Uchida; Akihiro Sudo
Journal:  Clin Exp Metastasis       Date:  2011-07-30       Impact factor: 5.150

2.  Growth rate of lung metastases and S-phase fraction as determined by flow cytometry from the primary tumour in 25 patients with bone or soft-tissue sarcomas.

Authors:  C Blomqvist; R Huuhtanen; Y Pan; T Wiklund; M Tarkkanen; M Virolainen; B Tribukait
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

3.  Linear mixed-effects models for estimation of pulmonary metastasis growth rate: implications for CT surveillance in patients with sarcoma.

Authors:  Ulysses Isidro; Liam M O'Brien; Ronnie Sebro
Journal:  Br J Radiol       Date:  2020-08-26       Impact factor: 3.039

4.  Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung.

Authors:  Tomoki Nakamura; Akihiko Matsumine; Motoshi Takao; Atsuhiro Nakatsuka; Takao Matsubara; Kunihiro Asanuma; Akihiro Sudo
Journal:  Onco Targets Ther       Date:  2017-01-31       Impact factor: 4.147

5.  (Neo)adjuvant chemotherapy and interdigitated split-course hyperfractionated radiation in high risk soft tissue sarcoma - Results from a large single-institution series.

Authors:  Riikka Nevala; Erkki Tukiainen; Maija Tarkkanen; Tom Böhling; Carl Blomqvist; Mika Sampo
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

6.  Evaluation of the stability and intratumoral delivery of foreign transgenes encoded by an oncolytic Foamy Virus vector.

Authors:  Karol M Budzik; Rebecca A Nace; Yasuhiro Ikeda; Stephen J Russell
Journal:  Cancer Gene Ther       Date:  2022-02-10       Impact factor: 5.854

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.